Viking Therapeutics annual meeting elects two Class II directors, ratifies auditor

Viking Therapeutics, Inc.

J. Matthew Singleton elected with 28.6M votes for; S. Kathryn Rouan with 22.0M for.
Ratification of CBIZ CPAs as independent auditor for FY 2026 approved (78.4M for, 1.2M against).
Advisory vote on named executive officer compensation passed (30.0M for, 12.8M against).
Quorum achieved with 80.1M shares (69.1% of outstanding) represented at the meeting.

item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001193125-26-239535
form_type: 8-K
ticker: VKTX
cik: 0001607678
company_name: Viking Therapeutics, Inc.
filed_at: 2026-05-26T20:48:01+00:00
discovered_at: 2026-05-26T20:48:54.654168+00:00
generated_at: 2026-05-26T20:52:26.036947+00:00
sec_items: ["5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.25
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001193125-26-239535
json_url: https://secwatch.observer/filing/0001193125-26-239535.json
markdown_url: https://secwatch.observer/filing/0001193125-26-239535.md
text_url: https://secwatch.observer/filing/0001193125-26-239535.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1607678/000119312526239535/0001193125-26-239535-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1607678/000119312526239535/vktx-20260519.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001193125-26-239535

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.